Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: M
Results 41 - 50 of 606 shown below

  • malignant fibrous histiocytoma

    Y-F Lee, M John, S Edwards, J Clark, P Flohr, K Maillard, M Edema, L Baker, D C Mangham, R Grimer, R Wooster, J M Thomas, C Fisher, I Judson and C S Cooper

    Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling

    doi:10.1038/sj.bjc.6600766

    Abstract | Full article | PDF

  • W-H Weng, J Åhlén, W-O Lui, O Brosjö, S-T Pang, A von Rosen, G Auer, O Larsson and C Larsson

    Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis

    doi:10.1038/sj.bjc.6601069

    Abstract | Full article | PDF

  • malignant germ cell tumour

    D A Anthoney, M J McKean, J T Roberts, A W Hutcheon, J Graham, W Jones, J Paul and S B Kaye

    Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours

    doi:10.1038/sj.bjc.6601528

    Abstract | Full article | PDF

  • malignant germ cell tumours

    S D Fosså, N Aass, S Harvei and S Tretli

    Increased mortality rates in young and middle-aged patients with malignant germ cell tumours

    doi:10.1038/sj.bjc.6601558

    Abstract | Full article | PDF

  • malignant glioma

    M R Graf, W Jia and R M Loria

    The neuro-steroid, 3beta androstene 17alpha diol exhibits potent cytotoxic effects on human malignant glioma and lymphoma cells through different programmed cell death pathways

    advance online publication, 2007-07-17 00:00:00.000;

    doi:10.1038/sj.bjc.6603894

    Abstract | Full article | PDF

  • T Saito, S Hama, H Izumi, F Yamasaki, Y Kajiwara, S Matsuura, K Morishima, T Hidaka, P Shrestha, K Sugiyama and K Kurisu

    Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity in glioma cells

    advance online publication, 2008-01-15 00:00:00.000;

    doi:10.1038/sj.bjc.6604160

    Abstract | Full article | PDF

  • D A Reardon, A Desjardins, J J Vredenburgh, S Gururangan, J H Sampson, S Sathornsumetee, R E McLendon, J E Herndon, J E Marcello, J Norfleet, A H Friedman, D D Bigner and H S Friedman

    Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

    advance online publication, 2009-11-17 00:00:00.000;

    doi:10.1038/sj.bjc.6605412

    Abstract | Full article | PDF

  • K Kohshi, Y Kinoshita, H Imada, N Kunugita, H Abe, H Terashima, N Tokui and S Uemura

    Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas

    doi:10.1038/sj.bjc.6690345

    Abstract | Full article | PDF

  • W K A Yung, R E Albright, J Olson, R Fredericks, K Fink, M D Prados, M Brada, A Spence, R J Hohl, W Shapiro, M Glantz, H Greenberg, R G Selker, N A Vick, R Rampling, H Friedman, P Phillips, J Bruner, N Yue, D Osoba, S Zaknoen and V A Levin

    A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

    doi:10.1054/bjoc.2000.1316

    Abstract | Full article | PDF

  • malignant gliomas

    A Yannopoulos, E Dimitriadis, A Scorilas, T Trangas, E Markakis and M Talieri

    mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete

    advance online publication, 2005-06-28 00:00:00.000;

    doi:10.1038/sj.bjc.6602642

    Abstract | Full article | PDF

  • malignant lymphoma

    M Mohren, I Markmann, K Jentsch-Ullrich, M Koenigsmann, G Lutze and A Franke

    Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis

    advance online publication, 2005-03-29 00:00:00.000;

    doi:10.1038/sj.bjc.6602504

    Abstract | Full article | PDF

  • A Okines, C S Thomson, C R Radstone, J M Horsman and B W Hancock

    Second primary malignancies after treatment for malignant lymphoma

    doi:10.1038/sj.bjc.6602731

    Abstract | Full article | PDF

  • K Remes, K-F Norrback, R Rosenquist, C Mehle, J Lindh and G Roos

    Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse

    doi:10.1054/bjoc.1999.0970

    Abstract | Full article | PDF

  • malignant melanoma

    U Hofmann, M Szedlak, W Rittgen, E G Jung and D Schadendorf

    Primary staging and follow-up in melanoma patients – monocenter evaluation of methods, costs and patient survival

    doi:10.1038/sj.bjc.6600428

    Abstract | Full article | PDF

  • D B McKenna, D Stockton, D H Brewster and V R Doherty

    Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland

    doi:10.1038/sj.bjc.6600692

    Abstract | Full article | PDF

  • G C de Gast, D Batchelor, M J Kersten, F A Vyth-Dreese, J Sein, W F van de Kasteele, W J Nooijen, O E Nieweg, M A de Waal and W Boogerd

    Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNalpha in patients with metastatic melanoma

    doi:10.1038/sj.bjc.6600717

    Abstract | Full article | PDF

  • M Lambe, P Blomqvist and R Bellocco

    Seasonal variation in the diagnosis of cancer: a study based on national cancer registration in Sweden

    doi:10.1038/sj.bjc.6600901

    Abstract | Full article | PDF

  • J D Shields, M Borsetti, H Rigby, S J Harper, P S Mortimer, J R Levick, A Orlando and D O Bates

    Lymphatic density and metastatic spread in human malignant melanoma

    doi:10.1038/sj.bjc.6601571

    Abstract | Full article | PDF

  • R M MacKie and C A Bray

    Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma

    doi:10.1038/sj.bjc.6601595

    Abstract | Full article | PDF

  • J H Olsen, S Friis, K Frederiksen, J K McLaughlin, L Mellemkjaer and H Møller

    Atypical cancer pattern in patients with Parkinson's disease

    advance online publication, 2004-12-07 00:00:00.000;

    doi:10.1038/sj.bjc.6602279

    Abstract | Full article | PDF

  • A Downing, J A Newton-Bishop and D Forman

    Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993–2003

    advance online publication, 2006-06-06 00:00:00.000;

    doi:10.1038/sj.bjc.6603216

    Abstract | Full article | PDF

  • M Mowbray, D L Stockton and V R Doherty

    Changes in the site distribution of malignant melanoma in South East Scotland (1979–2002)

    advance online publication, 2007-02-13 00:00:00.000;

    doi:10.1038/sj.bjc.6603612

    Abstract | Full article | PDF

  • M Fojtova, V Boudny, A Kovarik, L Lauerova, L Adamkova, K Souckova, J Jarkovsky and J Kovarik

    Development of IFN-italic gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells

    advance online publication, 2007-06-19 00:00:00.000;

    doi:10.1038/sj.bjc.6603849

    Abstract | Full article | PDF

  • A Thies, P Dautel, A Meyer, U Pfüller and U Schumacher

    Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model

    advance online publication, 2007-11-20 00:00:00.000;

    doi:10.1038/sj.bjc.6604106

    Abstract | Full article | PDF

  • J M Karjalainen, M Reinikainen and V-M Kosma

    p21WAF1/CIP1expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival

    doi:10.1038/sj.bjc.6690143

    Abstract | Full article | PDF

  • M Deichmann, M Thome, M Bock, A Jäckel, V Waldmann and H Näher

    The human herpesvirus-type 8 is not involved in malignant melanoma

    doi:10.1038/sj.bjc.6690322

    Abstract | Full article | PDF

  • R Hipfel, B Schittek, Y Bodingbauer and C Garbe

    Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization

    doi:10.1054/bjoc.1999.1055

    Abstract | Full article | PDF

  • G Palmieri, A Cossu, P A Ascierto, G Botti, M Strazzullo, A Lissia, M Colombino, M Casula, C Floris, F Tanda, M Pirastu and G Castello

    Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases

    doi:10.1054/bjoc.2000.1513

    Abstract | Full article | PDF

  • A Håkansson, B Gustafsson, L Krysander, B Hjelmqvist, B Rettrup and L Håkansson

    Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes

    doi:10.1054/bjoc.2001.2169

    Abstract | Full article | PDF

  • malignant melanoma of soft parts

    S M Langezaal, J F Graadt van Roggen, A M Cleton-Jansen, J J Baelde and P C W Hogendoorn

    Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts)

    doi:10.1054/bjoc.2000.1628

    Abstract | Full article | PDF

  • malignant mesothelioma

    A K Nowak, M J Byrne, R Williamson, G Ryan, A Segal, D Fielding, P Mitchell, A W Musk and B W S Robinson

    A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma

    doi:10.1038/sj.bjc.6600505

    Abstract | Full article | PDF

  • J G Edwards, J McLaren, J L Jones, D A Waller and K J O'Byrne

    Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura

    doi:10.1038/sj.bjc.6600920

    Abstract | Full article | PDF

  • M Tomasetti, M R Rippo, R Alleva, S Moretti, L Andera, J Neuzil and A Procopio

    alpha-Tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells

    advance online publication, 2004-03-23 00:00:00.000;

    doi:10.1038/sj.bjc.6601707

    Abstract | Full article | PDF

  • Y Ohta, V Shridhar, R K Bright, G P Kalemkerian, W Du, M Carbone, Y Watanabe and H I Pass

    VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours

    doi:10.1038/sj.bjc.6690650

    Abstract | Full article | PDF

  • A-M Björkqvist, M Wolf, S Nordling, L Tammilehto, A Knuuttila, J Kere, K Mattson and S Knuutila

    Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis

    doi:10.1038/sj.bjc.6690816

    Abstract | Full article | PDF

  • Y Li and P Heldin

    Hyaluronan production increases the malignant properties of mesothelioma cells

    doi:10.1054/bjoc.2001.1922

    Abstract | Full article | PDF

  • J G Edwards, G Cox, A Andi, J L Jones, R A Walker, D A Waller and K J O'Byrne

    Angiogenesis is an independent prognostic factor in malignant mesothelioma

    doi:10.1054/bjoc.2001.1997

    Abstract | Full article | PDF

  • F Le Pimpec-Barthes, I Bernard, I Abd Alsamad, A Renier, L Kheuang, J Fleury-Feith, P Devauchelle, F Quintin Colonna, M Riquet and M C Jaurand

    Pleuro-pulmonary tumours detected by clinical and chest X-ray analyses in rats transplanted with mesothelioma cells

    doi:10.1038/sj.bjc.6693248

    Abstract | Full article | PDF

  • malignant neoplasms

    A H Olsen, A Jensen, S H Njor, E Villadsen, W Schwartz, I Vejborg and E Lynge

    Breast cancer incidence after the start of mammography screening in Denmark

    doi:10.1038/sj.bjc.6600712

    Abstract | Full article | PDF

  • A H Olsen, D M Parkin and P Sasieni

    Cancer mortality in the United Kingdom: projections to the year 2025

    advance online publication, 2008-10-14 00:00:00.000;

    doi:10.1038/sj.bjc.6604710

    Abstract | Full article | PDF

  • A H Olsen, K Bihrmann, M-B Jensen, I Vejborg and E Lynge

    Breast density and outcome of mammography screening: a cohort study

    advance online publication, 2009-03-17 00:00:00.000;

    doi:10.1038/sj.bjc.6604989

    Abstract | Full article | PDF